Advertisement
U.S. markets closed

PureTech Health plc (PRTC)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
26.81+2.41 (+9.88%)
At close: 03:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close24.40
Open26.25
Bid15.02 x 900
Ask43.20 x 900
Day's Range26.25 - 29.11
52 Week Range17.08 - 33.07
Volume35,526
Avg. Volume3,680
Market Cap723.736M
Beta (5Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)-1.70
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est58.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PRTC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PureTech Health plc
    ITOS: What does Argus have to say about ITOS?ITEOS THERAPEUTICS INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more